Imaging NFkB Activity in Relation to Animal Behavior in Peripheral Neuropathy

周围神经病变中与动物行为相关的 NFkB 活性成像

基本信息

  • 批准号:
    8455517
  • 负责人:
  • 金额:
    $ 5.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-01-01 至 2014-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Herniation of the intervertebral disc (IVD) may be associated with nerve root compression and biochemical irritation that contributes to inflammatory cell infiltration and associated generation of pain or radiculopathy. Tumor necrosis factor-a (TNFa) is a pro-inflammatory cytokine that is thought to be an early mediator of radiculopathy and neuropathic pain in herniated IVD. TNFa-induced inflammation is regulated by the transcription factor NF-kB, with data showing that NF-kB antagonism can reduce nociceptive pain following peripheral nerve injury. The main hypothesis of work proposed in this NRSA Fellowship is that regional NF-kB activity, determined via noninvasive, longitudinal in vivo imaging, has a direct relationship to rodent function and pain-related behaviors in a model of peripheral nerve injury. The secondary hypothesis is that localized inhibition of NF-kB in the region of nerve injury can modify pain-related behaviors. In Aim 1, a model of chronic constriction injury (CCI) of the sciatic nerve will be developed in transgenic mice (NFkB-RE-Luc) containing a luciferase NF-kB reporter. Regional NF-kB activity in the nervous system will be monitored longitudinally and non-invasively via in vivo luminescence imaging, along with time-matched measures of function (e.g., gait), pain-related behaviors (mechanical and thermal hypersensitivity, running wheel activity), and characterization of the inflammatory cell infiltrate. Measures of function, pain, and inflammatory cell populations will be correlated with regional NF-kB in the CCI and sham-operated controls in order to evaluate the contributions of NF-kB to symptoms and dysfunction. In Aim 2, the therapeutic efficacy of curcumin as an NF-kB inhibitor will be evaluated following CCI via noninvasive, in vivo imaging and markers of function and pain-related behaviors. Curcumin depots will be delivered perineural to the sciatic nerve following CCI in NFkB-RE-Luc transgenic mice, and mice will be tracked longitudinally for NF-kB activity via in vivo luminescence imaging. A separate set of animals will be similarly studied following CCI and perineural delivery of the specific NF-kB inhibitor, SC514. Measures of function, pain behaviors, and inflammatory cell characterizations will be obtained at all times and examined for correlations with NF-kB activity in both models, in order to assess an ability for local curcumin delivery to antagonize NF-kB activity, as well as symptoms and dysfunction associated with CCI. The applicant will work with the Sponsor and mentoring team to learn new techniques in state-of-the-art in vivo imaging, gait analysis, and pain assessments that will advance both the applicant's career and the translation of imaging and functional biomarkers for the study of musculoskeletal disease. The applicant will obtain broader training in research methodology, animal models, grant and manuscript preparation and responsible conduct in research that will prepare him for an academic career in bioengineering.
描述(由申请方提供):椎间盘突出(IVD)可能与神经根压迫和生化刺激相关,导致炎性细胞浸润和相关疼痛或神经根病的产生。肿瘤坏死因子-α(TNF α)是一种促炎细胞因子,被认为是椎间盘突出中神经根病和神经性疼痛的早期介质。TNF α诱导的炎症受转录因子NF-kB的调节,数据显示NF-kB拮抗作用可以减少外周神经损伤后的伤害性疼痛。这项NRSA奖学金提出的主要假设是,通过非侵入性,纵向体内成像确定的区域NF-kB活性与周围神经损伤模型中啮齿动物的功能和疼痛相关行为有直接关系。第二个假设是在神经损伤区域局部抑制NF-kB可以改变疼痛相关行为。在目的1中,将在含有荧光素酶NF-κ B报告基因的转基因小鼠(NF-κ B-RE-Luc)中开发坐骨神经的慢性压迫性损伤(CCI)模型。神经系统中的局部NF-kB活性将通过体内发光成像,沿着时间匹配的功能测量(例如,步态)、疼痛相关行为(机械和热超敏反应、转轮活动)和炎性细胞浸润的表征。在CCI和假手术对照组中,功能、疼痛和炎性细胞群的测量将与区域NF-kB相关,以评估NF-kB对症状和功能障碍的贡献。在目标2中,姜黄素作为NF-κ B抑制剂的治疗效果将在CCI后通过非侵入性体内成像和功能和疼痛相关行为的标记物进行评估。在NFkB-RE-Luc转基因小鼠中CCI后,将姜黄素贮库神经周递送至坐骨神经,并且将通过体内发光成像纵向追踪小鼠的NF-kB活性。在CCI和神经周递送特异性NF-κ B抑制剂SC 514后,将类似地研究单独的一组动物。将在所有时间获得功能、疼痛行为和炎性细胞表征的测量,并检查两种模型中与NF-κ B活性的相关性,以评估局部姜黄素递送拮抗NF-κ B活性的能力,以及与CCI相关的症状和功能障碍。申请人将与申办者和指导团队合作,学习最先进的体内成像,步态分析和疼痛评估的新技术,这将促进申请人的职业生涯以及成像和功能生物标志物的翻译,用于肌肉骨骼疾病的研究。申请人将获得更广泛的研究方法,动物模型,赠款和手稿准备和负责任的研究行为的培训,这将为他在生物工程的学术生涯做好准备。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert D. Bowles其他文献

Robert D. Bowles的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert D. Bowles', 18)}}的其他基金

Sequence-specific CRISPR mediated inflammatory cytokine receptor modulation for the treatment of inflammatory intervertebral disc pathology
序列特异性 CRISPR 介导的炎性细胞因子受体调节用于治疗炎性椎间盘病理
  • 批准号:
    10454149
  • 财政年份:
    2019
  • 资助金额:
    $ 5.22万
  • 项目类别:
Sequence-specific CRISPR mediated inflammatory cytokine receptor modulation for the treatment of inflammatory intervertebral disc pathology
序列特异性 CRISPR 介导的炎性细胞因子受体调节用于治疗炎性椎间盘病理
  • 批准号:
    10669111
  • 财政年份:
    2019
  • 资助金额:
    $ 5.22万
  • 项目类别:
Sequence-specific CRISPR mediated inflammatory cytokine receptor modulation for the treatment of inflammatory intervertebral disc pathology
序列特异性 CRISPR 介导的炎性细胞因子受体调节用于治疗炎性椎间盘病理
  • 批准号:
    10229422
  • 财政年份:
    2019
  • 资助金额:
    $ 5.22万
  • 项目类别:
Sequence-Specific CRISPR Mediated Inflammatory Cytokine Receptor Modulation for the Treatment of Inflammatory Intervertebral Disc Pathology
序列特异性 CRISPR 介导的炎症细胞因子受体调节用于治疗炎症性椎间盘病理学
  • 批准号:
    9105355
  • 财政年份:
    2015
  • 资助金额:
    $ 5.22万
  • 项目类别:
Sequence-Specific CRISPR Mediated Inflammatory Cytokine Receptor Modulation for the Treatment of Inflammatory Intervertebral Disc Pathology
序列特异性 CRISPR 介导的炎症细胞因子受体调节用于治疗炎症性椎间盘病理学
  • 批准号:
    9284378
  • 财政年份:
    2015
  • 资助金额:
    $ 5.22万
  • 项目类别:
Imaging NFkB Activity in Relation to Animal Behavior in Peripheral Neuropathy
周围神经病变中与动物行为相关的 NFkB 活性成像
  • 批准号:
    8600602
  • 财政年份:
    2013
  • 资助金额:
    $ 5.22万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 5.22万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 5.22万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 5.22万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 5.22万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 5.22万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 5.22万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 5.22万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了